Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts ; volume:9 ; number:1 ; day:11 ; month:4 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (11.4.2019), 1-10, 12.2019

Classification: Naturwissenschaften

Creator: Leiting, Jennifer L.
Hernandez, Matthew C.
Yang, Lin
Bergquist, John R.
Ivanics, Tommy
Graham, Rondell P.
Truty, Mark J.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-019-42470-w

URN: urn:nbn:de:101:1-2019042521020063932922

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Leiting, Jennifer L.
Hernandez, Matthew C.
Yang, Lin
Bergquist, John R.
Ivanics, Tommy
Graham, Rondell P.
Truty, Mark J.
SpringerLink (Online service)

Other Objects (12)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Patient-derived xenografts as preclinical neuroblastoma models

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Molecular profiling of patient-derived breast cancer xenografts

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Patient-derived xenografts as compatible models for precision oncology

Patient-derived xenografts: a relevant preclinical model for drug development

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Factors associated with engraftment success of patient-derived xenografts of breast cancer

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

Related objects

Reset password